New medical devices take years to reach the market – and many never make it, representing a huge loss of time and investment. Jon Johnson, a researcher at Cambridge’s Institute for Manufacturing, is looking at ways of making the process of commercialisation more efficient.
Like many high-tech industries, the medical sector is strongly motivated to increase the efficiency and profitability of its new product development process. The industry faces particular challenges. Biotechnology and healthcare developments require huge investment in terms of finance and resources, as well as in-depth research and clinical trials. According to the Food and Drug Administration,…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
